Trials / Completed
CompletedNCT04573036
A Trial of HRS4800 Tables in Healthy Male Subjects
A Phase 1, Single Center, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Effect of Food on the Pharmacokinetics of HRS4800 in Healthy Male Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Atridia Pty Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a single-site study to evaluate the safety, tolerability and pharmacokinetics (PK) of single dose administration of HRS4800, and the effect of food on the PK of HRS4800 in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS4800 tablets | single oral administration |
| DRUG | Placebo tablets | single oral administration |
Timeline
- Start date
- 2020-11-12
- Primary completion
- 2021-09-20
- Completion
- 2021-09-20
- First posted
- 2020-10-05
- Last updated
- 2022-03-31
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT04573036. Inclusion in this directory is not an endorsement.